1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO
60.08 1.03 (1.74%)
1.4M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Halozyme Therapeutics Inc. is on 06 Aug 2025 for the purpose of Halozyme Therapeutics Inc Second Quarter Earnings Results for 2025 See details

Halozyme Therapeutics Inc. - HALO - stock price prediction, stock price target, analyst ratings from 10 analysts

Halozyme Therapeutics Inc. has a share price target of US$ 66, revenue growth forecast of 22.9%, and profit growth estimate of 34.4% for FY25, based on top 10 analyst calls.